Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

Core Points - Axsome Therapeutics, Inc. will report its financial results for Q1 2024 on May 6, 2024, before U.S. market opening [1] - A conference call will be held at 8:00 a.m. Eastern Time on the same day to discuss the results and provide a business update [1] Company Overview - Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders with limited treatment options [2] - The company aims to transform the treatment approach for CNS conditions through innovative mechanisms of action [2] - Axsome is committed to improving patient lives and providing new therapeutic options for healthcare providers [2]